Skip to content

BIO FRONTIER

  • Home
  • Artificial intelligence
  • Biotechnology
  • Genetics
  • Medical Technology
    • Home
    • Uncategorized
    • Amgen upgraded to buy at UBS on potential of MariTide, olpasiran

Amgen upgraded to buy at UBS on potential of MariTide, olpasiran

Jan 6, 2026

Post navigation

Jazz boasts of first-line Ziihera data in gastroesophageal cancers
Esco Aster signe avec Shine-On Biomedical un contrat de fabrication clinique d’exosomes, conforme aux BPF en vigueur, pour une nouvelle plateforme HLA-G ciblant l’administration de médicaments exosomiques
  • PR Newswire
  • GlobeNewswire
  • Contact
  • Privacy Policy

BIO FRONTIER

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.